US$18.13: That's What Analysts Think, Inc. (NASDAQ:LZ) Is Worth After Its Latest Results

Simply Wall St
May 15, 2022
Source: Shutterstock

There's been a notable change in appetite for, Inc. (NASDAQ:LZ) shares in the week since its quarterly report, with the stock down 15% to US$11.95. Sales of US$154m came in 2.4% ahead of expectations, although statutory earnings didn't fare nearly so well, recording a loss of US$0.15, a 16% miss. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.

View our latest analysis for

NasdaqGS:LZ Earnings and Revenue Growth May 15th 2022

Taking into account the latest results, the current consensus from's nine analysts is for revenues of US$654.8m in 2022, which would reflect a decent 10% increase on its sales over the past 12 months. Losses are predicted to fall substantially, shrinking 56% to US$0.29. Before this latest report, the consensus had been expecting revenues of US$654.2m and US$0.28 per share in losses.

As a result, it's unexpected to see that the consensus price target fell 8.8% to US$18.13, with the analysts seemingly becoming more concerned about ongoing losses, despite making no major changes to their forecasts. Fixating on a single price target can be unwise though, since the consensus target is effectively the average of analyst price targets. As a result, some investors like to look at the range of estimates to see if there are any diverging opinions on the company's valuation. Currently, the most bullish analyst values at US$31.00 per share, while the most bearish prices it at US$12.00. We would probably assign less value to the analyst forecasts in this situation, because such a wide range of estimates could imply that the future of this business is difficult to value accurately. As a result it might not be a great idea to make decisions based on the consensus price target, which is after all just an average of this wide range of estimates.

Of course, another way to look at these forecasts is to place them into context against the industry itself. We would highlight that's revenue growth is expected to slow, with the forecast 14% annualised growth rate until the end of 2022 being well below the historical 19% growth over the last year. Juxtapose this against the other companies in the industry with analyst coverage, which are forecast to grow their revenues (in aggregate) 6.9% per year. So it's pretty clear that, while's revenue growth is expected to slow, it's still expected to grow faster than the industry itself.

The Bottom Line

The most important thing to take away is that the analysts reconfirmed their loss per share estimates for next year. Happily, there were no major changes to revenue forecasts, with the business still expected to grow faster than the wider industry. The consensus price target fell measurably, with the analysts seemingly not reassured by the latest results, leading to a lower estimate of's future valuation.

Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. We have forecasts for going out to 2024, and you can see them free on our platform here.

And what about risks? Every company has them, and we've spotted 3 warning signs for you should know about.

Discounted cash flow calculation for every stock

Simply Wall St does a detailed discounted cash flow calculation every 6 hours for every stock on the market, so if you want to find the intrinsic value of any company just search here. It’s FREE.

Make Confident Investment Decisions

Simply Wall St's Editorial Team provides unbiased, factual reporting on global stocks using in-depth fundamental analysis.
Find out more about our editorial guidelines and team.